ZATAMIL 0.1% OINTMENT mometasone furoate 0.1% w/w (1 mg/g) ointment tube Australia - engelsk - Department of Health (Therapeutic Goods Administration)

zatamil 0.1% ointment mometasone furoate 0.1% w/w (1 mg/g) ointment tube

ego pharmaceuticals pty ltd - mometasone furoate, quantity: 1 mg/g - ointment - excipient ingredients: hexylene glycol; citric acid; light liquid paraffin; purified water; white soft paraffin; polyethylene; colloidal anhydrous silica; cetostearyl alcohol - for the short term (up to four continuous weeks) relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses such as psoriasis and atopic dermatitis.

UNICLAR AQUEOUS NASAL SPRAY 0.05 % mometasone furoate (as monohydrate) 50 microgram/actuation, suspension spray, pump actuated metered dose aerosol Australia - engelsk - Department of Health (Therapeutic Goods Administration)

uniclar aqueous nasal spray 0.05 % mometasone furoate (as monohydrate) 50 microgram/actuation, suspension spray, pump actuated metered dose aerosol

organon pharma pty ltd - mometasone furoate, quantity: 50 microgram/actuation - spray, suspension - excipient ingredients: benzalkonium chloride; citric acid monohydrate; sodium citrate dihydrate; dispersible cellulose; glycerol; citric acid; polysorbate 80; purified water - uniclar aqueous nasal spray 0.05% is indicated for the treatment of symptoms associated with seasonal allergic rhinitis and perennial allergic rhinitis and the prophylaxis of seasonal allergic rhinitis in adults, adolescents and children between the ages of 3 and 11 years. uniclar aqueous nasal spray 0.05% is also indicated for the treatment of nasal polyps in adult patients 18 years of age and older. uniclar aqueous nasal spray 0.05% is indicated for the treatment of symptoms associated with acute rhinosinusitis in patients 12 years of age and older without signs or symptoms of severe bacterial infection.

ZATAMIL 0.1% HYDROGEL mometasone furoate 0.1% w/w (1 mg/g) gel tube Australia - engelsk - Department of Health (Therapeutic Goods Administration)

zatamil 0.1% hydrogel mometasone furoate 0.1% w/w (1 mg/g) gel tube

ego pharmaceuticals pty ltd - mometasone furoate, quantity: 1 mg/g - gel - excipient ingredients: hexylene glycol; citric acid; hypromellose; purified water - for the short term (up to four continuous weeks) relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses such as psoriasis and atopic dermatitis.

ZATAMIL 0.1% LOTION mometasone furoate 0.1% w/w (1 mg/g) lotion bottle Australia - engelsk - Department of Health (Therapeutic Goods Administration)

zatamil 0.1% lotion mometasone furoate 0.1% w/w (1 mg/g) lotion bottle

ego pharmaceuticals pty ltd - mometasone furoate, quantity: 1 mg/g - lotion - excipient ingredients: industrial methylated spirit; citric acid; propylene glycol; hypromellose; purified water - for the short term (up to four continuous weeks) relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses such as psoriasis and atopic dermatitis.,zatamil lotion is suitable for use in scalp psoriaris and application to other areas of the body.

Mometasone 0.1% cream Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

mometasone 0.1% cream

a a h pharmaceuticals ltd - mometasone furoate - cutaneous cream - 1mg/1gram

Mometasone 0.1% cream Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

mometasone 0.1% cream

alliance healthcare (distribution) ltd - mometasone furoate - cutaneous cream - 1mg/1gram

Mometasone 0.1% cream Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

mometasone 0.1% cream

auden mckenzie (pharma division) ltd - mometasone furoate - cutaneous cream - 1mg/1gram

Mometasone 0.1% cream Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

mometasone 0.1% cream

waymade healthcare plc - mometasone furoate - cutaneous cream - 1mg/1gram